⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT March 2, 2026

Bactroban - Nasensalbe (Nasensalbe)

📷 EU Safety Watch placeholder
Bactroban - Nasensalbe (Nasensalbe)
📷 EU Safety Watch placeholder
Bactroban nasal ointment is subject to a parallel export ban. Supply is delayed due to manufacturing issues.
⚠️
Shortage ongoing
CALCIUM MUPIROCINAT DIHYDRAT is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? This is a nose ointment called Bactroban. It fights germs in the nose.

What's happening? The ointment is not available right now. It will come back in July.

Does this affect me? If you use this ointment, you may not find it in pharmacies now.

What should I do? Ask your pharmacist or doctor for advice. They can help you find another option.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
CALCIUM MUPIROCINAT DIHYDRAT
Agency-published detail

🚫 Parallel export ban active · ATC: D06AX09 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Glaxosmithkline Pharma GmbH, Wienerbergstraße 7, 1100 Wien, Österreich · Affected packs: 3 g Schachtel, Tube [Nicht verfügbar, since 2026-03-01, resupply 2026-07-20]

First published
March 2, 2026
Last refreshed by us
15 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Bactroban - Nasensalbe (Nasensalbe). Bactroban nasal ointment is subject to a parallel export ban. Supply is delayed due to manufacturing issues.
▸ When was this alert issued?
This alert was issued on March 2, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.